Alector Ownership | Who Owns Alector?
Alector Ownership Summary
Alector is owned by 75.85% institutional investors, 9.97% insiders, and 14.17% retail investors. Fmr is the largest institutional shareholder, holding 15.20% of ALEC shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 5.33% of its assets in Alector shares.
ALEC Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Alector | 75.85% | 9.97% | 14.17% |
Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
Industry | Biotech Stocks | 68.48% | 9.65% | 21.87% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Fmr | 14.69M | 15.20% | $27.76M |
Ra capital management | 9.70M | 10.03% | $18.32M |
Blackrock | 9.10M | 9.70% | $41.32M |
Blackrock funding, inc. /de | 9.14M | 9.45% | $17.27M |
Vanguard group | 5.62M | 5.81% | $10.61M |
Merck | 3.55M | 3.67% | $6.70M |
Morgan stanley | 3.01M | 3.20% | $13.64M |
Geode capital management | 1.91M | 1.98% | $3.62M |
State street | 1.85M | 1.91% | $3.50M |
Jpmorgan chase | 1.64M | 1.70% | $3.10M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Merck | 3.55M | 2.60% | $6.70M |
New leaf venture partners | 339.57K | 0.86% | $641.78K |
5am venture management | 995.84K | 0.45% | $1.88M |
Dafna capital management | 912.93K | 0.44% | $1.73M |
Medici capital | 167.19K | 0.39% | $315.99K |
Euclidean capital | 1.31M | 0.34% | $2.47M |
Sio capital management | 615.63K | 0.33% | $1.16M |
Ikarian capital | 950.00K | 0.24% | $1.80M |
Ra capital management | 9.70M | 0.24% | $18.32M |
Adar1 capital management | 368.33K | 0.14% | $696.14K |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Ra capital management | 9.70M | 0.24% | 9.70M |
Merck | 3.55M | 2.60% | 3.55M |
5am venture management | 995.84K | 0.45% | 995.84K |
Ikarian capital | 950.00K | 0.24% | 950.00K |
Blackrock | 9.10M | 0.00% | 617.87K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Deep track capital, lp | - | - | -4.63M |
Ecor1 capital | - | - | -4.06M |
Braidwell lp | - | - | -2.16M |
Soleus capital management | - | - | -1.21M |
Jpmorgan chase | 1.64M | 0.00% | -1.09M |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Ra capital management | 9.70M | 0.24% | 9.70M | $18.32M |
Merck | 3.55M | 2.60% | 3.55M | $6.70M |
5am venture management | 995.84K | 0.45% | 995.84K | $1.88M |
Ikarian capital | 950.00K | 0.24% | 950.00K | $1.80M |
Sio capital management | 615.63K | 0.33% | 615.63K | $1.16M |
Sold Out
Holder | Change |
---|---|
Nelson, van denburg & campbell wealth management group | -13.00 |
Parallel advisors | -15.00 |
Northwestern mutual wealth management | -50.00 |
Srs capital advisors | -84.00 |
Motco | -125.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Dec 31, 2024 | 149 | -9.15% | 73,332,095 | 1.08% | 75 | 1.35% | 73 | 7.35% | 38 | -20.83% |
Sep 30, 2024 | 163 | 0.62% | 72,549,854 | -0.17% | 75 | 1.33% | 68 | -16.05% | 48 | -5.88% |
Jun 30, 2024 | 161 | 1.90% | 72,671,102 | -1.85% | 77 | 1.01% | 81 | -6.90% | 50 | 38.89% |
Mar 31, 2024 | 158 | 5.33% | 74,038,324 | 15.85% | 87 | 1.51% | 87 | 33.85% | 36 | -26.53% |
Dec 31, 2023 | 150 | 0.67% | 63,909,324 | 3.01% | 76 | 1.38% | 65 | -15.58% | 49 | 19.51% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Fidelity Growth Compy Commingled Pl S | 5.28M | 5.33% | 37.01K |
Fidelity Growth Compy Commingled Pl O | 5.02M | 5.16% | 13.10K |
Fidelity Growth Company Fund | 3.62M | 3.66% | - |
Fidelity Select Biotechnology | 3.54M | 3.57% | - |
Vanguard Total Stock Mkt Idx Inv | 2.43M | 2.45% | 62.10K |
Vanguard US Total Market Shares ETF | 2.37M | 2.39% | - |
iShares Russell 2000 ETF | 2.14M | 2.16% | -18.54K |
Fidelity Growth Company K6 | 1.26M | 1.28% | -18.13K |
Vanguard Institutional Extnd Mkt Idx Tr | 1.15M | 1.16% | - |
Fidelity Series Growth Company | 959.65K | 0.97% | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Mar 03, 2025 | Kenkare-Mitra Sara | President and Head of R&D | Sell | $42.66K |
Mar 03, 2025 | Rosenthal Arnon | Chief Executive Officer | Sell | $59.18K |
Mar 03, 2025 | GRASSO MARC | Chief Financial Officer | Sell | $26.55K |
Mar 03, 2025 | Romano Gary | Chief Medical Officer | Sell | $23.93K |
Dec 02, 2024 | GRASSO MARC | Chief Financial Officer | Sell | $41.54K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q1 | - | 4 |
2024 Q4 | - | 4 |
2024 Q3 | - | 7 |
2024 Q2 | - | 4 |
2024 Q1 | - | 4 |
ALEC Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools